Amptiv Biosciences, Inc. — Form D
Amptiv Biosciences, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-04. The offering totals $1.4M, of which $300K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-04-04
- Form: D
- Accession: 0002032327-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $300K
- Remaining: $1.1M
- Investors: 3
- Date of first sale: 2025-03-21
- Revenue range: Decline to Disclose
- SEC file number: 021-542961
Issuer
- Name: Amptiv Biosciences, Inc.
- CIK: 0002032327
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 11000 CEDAR AVE, STE 21, CLEVELAND, OH, 44106
- Phone: 216?-220?-4098
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Jon Armstrong | Director | Hudson, OH |
| Jonathan Bell | Director | South San Francisco, CA |
| Jonathan Bell | Executive Officer | South San Francisco, CA |
Other filings by this issuer (1)
More